CAMP4 Therapeutics Corpor... (CAMP)
NASDAQ: CAMP
· Real-Time Price · USD
1.67
0.12 (7.74%)
At close: Aug 15, 2025, 3:59 PM
1.67
0.30%
After-hours: Aug 15, 2025, 04:10 PM EDT
CAMP4 Therapeutics Income Statement
Financials in USD. Fiscal
year is
March - February.
Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 |
Revenue | 1.51M | 652K | 53.63M | 115.34M | 186.23M | 264.74M | 290M | 301.11M | 294.95M | 284.82M | 274.71M | 280.89M | 295.84M | 309.41M | 328.64M | 333.17M | 333.71M | 338.97M | 347.55M | 357.25M |
Cost of Revenue | 9.56M | 19.13M | 55.18M | 94.55M | 128.82M | 170.02M | 186.24M | 190.69M | 185.94M | 175.5M | 163.98M | 165.81M | 173.95M | 180.97M | 193.22M | 200.31M | 202.24M | 208.76M | 215.47M | 218.31M |
Gross Profit | 1.09M | 234K | 17.57M | 39.92M | 66.98M | 94.72M | 103.76M | 110.42M | 109.01M | 109.32M | 110.73M | 115.09M | 121.89M | 128.44M | 135.42M | 132.86M | 131.47M | 130.21M | 132.09M | 138.94M |
Operating Income | -53.31M | -53.09M | -122.47M | -112.17M | -102.02M | -90.72M | -10.94M | -13.06M | -19.89M | -22.73M | -25.65M | -21.31M | -13.21M | -9.08M | -22.53M | -27.78M | -36.47M | -61.13M | -45.12M | -43.47M |
Interest Income | 1.52M | 1.33M | 720K | 626K | 395K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -51.77M | -51.79M | -123.48M | -113.78M | -105.19M | -100.32M | -19.82M | -23.39M | -31.34M | -32.68M | -38.55M | -36.28M | -30.06M | -24.62M | -37.65M | -41.77M | -50.24M | -75.89M | -62.58M | -62.08M |
Net Income | -51.77M | -51.79M | -123.52M | -114.26M | -105.71M | -101.35M | -21.08M | -24.35M | -32.49M | -33.58M | -40.28M | -38.22M | -27.99M | -27.54M | -39.78M | -43.84M | -56.31M | -103.41M | -87.14M | -85.03M |
Selling & General & Admin | 15.59M | 14.91M | 29.22M | 45.04M | 64.14M | 83.65M | 88.31M | 94.94M | 99.21M | 101.05M | 103.41M | 102.39M | 100.9M | 102.04M | 104.31M | 106.46M | 107.87M | 110.58M | 111.26M | 112.63M |
Research & Development | 39.41M | 39M | 33.06M | 28.16M | 24.43M | 20.03M | 21.45M | 23.41M | 24.57M | 25.83M | 27.53M | 28.5M | 28.44M | 28.73M | 28.34M | 27.6M | 26.98M | 26.98M | 27.94M | 28.87M |
Other Expenses | -9.56M | -19.13M | -19.15M | -18.42M | -7.64M | 3.27M | 4.61M | 5.21M | 5.33M | 5.38M | 3.96M | 1.92M | -702K | -2.44M | -2.4M | -1.47M | -403K | -182K | 102K | 78K |
Operating Expenses | 54.82M | 44.07M | 53.55M | 65.59M | 82.37M | 108.48M | 114.78M | 123.57M | 129.11M | 132.26M | 136.38M | 136.4M | 134.76M | 136.02M | 138.37M | 140.23M | 141.66M | 145.79M | 148.9M | 152.67M |
Interest Expense | n/a | n/a | 1.41M | 2.98M | 4.66M | 6.28M | 6.51M | 6.41M | 6.26M | 8.48M | 10.67M | 13.01M | 15.32M | 15.16M | 15.21M | 15.26M | 15.49M | 15.91M | 17.02M | 18.72M |
Selling & Marketing Expenses | n/a | n/a | 8.88M | 18.5M | 29.52M | 40.22M | 43.82M | 46.93M | 47.39M | 47.51M | 48.27M | 47.58M | 48.56M | 50.21M | 51.62M | 53.06M | 53.48M | 56.36M | 56.4M | 58.77M |
Cost & Expenses | 54.82M | 53.74M | 99.27M | 150.68M | 211.29M | 278.5M | 301.02M | 314.26M | 315.05M | 307.76M | 300.36M | 302.2M | 308.71M | 316.99M | 331.59M | 340.53M | 343.9M | 354.55M | 364.36M | 370.98M |
Income Tax Expense | n/a | n/a | 38K | 473K | 525K | 1.03M | 1.26M | 954K | 1.15M | 899K | 836K | 1.04M | 1.09M | 567K | 681K | 614K | 561K | 27.52M | 24.56M | 22.95M |
Shares Outstanding (Basic) | 19.51M | 19.51M | 19.51M | 15.81M | 12.12M | 37.43M | 36.99M | 36.63M | 36.13M | 36.36M | 35.69M | 35.72M | 35.55M | 35.14M | 35.15M | 34.84M | 34.68M | 33.98M | 34.26M | 34.02M |
Shares Outstanding (Diluted) | 19.51M | 19.51M | 19.51M | 15.81M | 12.12M | 37.43M | 36.99M | 36.63M | 36.13M | 36.36M | 36.01M | 35.72M | 35.55M | 35.48M | 35.15M | 34.84M | 34.69M | 34.6M | 34.26M | 34.02M |
EPS (Basic) | -2.81 | -3.2 | -4.79 | -4.21 | -3.52 | -2.71 | -0.57 | -0.67 | -0.9 | -0.94 | -1.14 | -1.08 | -0.8 | -0.79 | -1.16 | -1.29 | -1.65 | -3.05 | -2.57 | -2.51 |
EPS (Diluted) | -2.81 | -3.2 | -4.79 | -4.21 | -3.52 | -2.71 | -0.57 | -0.67 | -0.9 | -0.94 | -1.13 | -1.07 | -0.79 | -0.78 | -1.14 | -1.27 | -1.63 | -3.03 | -2.57 | -2.51 |
EBITDA | -51.63M | -51.39M | -39.43M | -23.23M | -7.95M | 4.1M | 7.34M | -281K | -8.1M | -11.11M | -13.38M | -4.94M | 3.15M | 8.27M | 13.87M | 11.66M | 11.22M | 7.47M | 7.99M | 12.64M |
EBIT | -53.31M | -53.09M | -39.05M | -25.54M | -15.38M | -4.09M | -7.72M | -13.06M | -19.89M | -22.73M | -19.09M | -13.75M | -4.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 1.68M | 1.7M | 6.23M | 11.41M | 16.53M | 17.29M | 17.55M | 12.78M | 11.79M | 11.62M | 12.37M | 17.18M | 18.11M | 18.3M | 19.21M | 20.49M | 21.81M | 23.24M | 24.7M | 26.29M |